IP Library Assignment 061375/0536
Patent Assignment
Reel/Frame 061375/0536

Change of Name

Recorded: 2022-10-11 Pages: 17
Assignor
METHYLGENE INC.
Executed: 2022-07-19
Assignee
METHYLGENE ULC
4300 BANKERS HALL WEST, 888-3RD STREET S.W., CALGARY, ALBERTA, T2P5C5, CANADA
Covered Properties (2)
Inhibitors of Protein Tyrosine Kinase Activity
Patent: 8,389,541 →
Application: 13/341,604 →
Publication: US 2012/0108628
Processes and Intermediates for Preparing Fused Heterocyclic Kinase Inhibitors
Patent: 9,018,378 →
Application: 13/946,189 →
Publication: US 2013/0310564
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 11, 2022
From: METHYLGENE ULC
To: MIRATI THERAPEUTICS, INC.
Reel/Frame 061375/0825 →